Current Treatment of Alopecia Areata

Journal of Investigative Dermatology Symposium Proceedings

Volumn 16, Issue 1, 2013, Pages S42-S44

  Shapiro, Jerry ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYCLOBUTANE DERIVATIVE; CYCLOPROPANE DERIVATIVE; CYCLOSPORIN; DERMATOLOGICAL AGENT; DIPHENCYPRONE; DITHRANOL; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MINOXIDIL; SQUARIC ACID DIBUTYL ESTER;

ALOPECIA AREATA; HUMAN; INTRADERMAL DRUG ADMINISTRATION; INTRALESIONAL DRUG ADMINISTRATION; PUVA; REVIEW; SELF HELP;

ADMINISTRATION, CUTANEOUS; ADRENAL CORTEX HORMONES; ALOPECIA AREATA; ANTHRALIN; CYCLOBUTANES; CYCLOPROPANES; CYCLOSPORINE; DERMATOLOGIC AGENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRALESIONAL; METHOTREXATE; MINOXIDIL; PUVA THERAPY; SELF-HELP GROUPS;

EID: 84907227632     PISSN: 10870024     EISSN: 15291774     Source Type: Journal    
DOI: 10.1038/jidsymp.2013.14     Document Type: Review

References (5)

1. Alkhalifah, A., Alsantali, A., Wang, E., et al. Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol 62 (2010), 177–188.
2. Alkhalifah, A., Alsantali, A., Wang, E., et al. Alopecia areata update: part II. Treatment. J Am Acad Dermatol, 62, 2010, 177.
3. Shapiro, J., Dermatologic Therapy: Alopecia Areata Update, 24 Number 3, 2011, Wiley, Blackwell Publishing, Hoboken, NJ, 301.
4. Tosti, A., Piraccini, B.M., Pazzaglia, M., et al. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis. J Am Acad Dermatol 49 (2003), 96–98.
5. Willemsen, R., Vanderlinden, J., Deconinck, A., et al. Hypnotherapeutic management of alopecia areata. J Am Acad Dermatol 55 (2006), 233–237.